FAQ

Restylane is a range of products for facial aesthetic treatments made in Sweden. They are designed to effectively reduce the appearance of unwanted wrinkles, contour and create volume in facial features such as the cheeks, chin and lips, and to revitalise the skin. Restylane is a gel based on stabilised hyaluronic acid. Hyaluronic acid (HA) is a substance that naturally exists in your body. The gel is injected into the skin through a needle or cannula.

A treatment with Restylane provides an easy way to enhance your appearance. The result of a single treatment can be seen instantly, and lasts around one year. With Restylane you will achieve a natural looking result that does not affect facial expression.
Restylane is the most scientifically documented HA based dermal filler in the world with comprehensive studies that support its safety and efficacy. Restylane has been used in over 20 million treatments worldwide since 1996.

Restylane was the first product of its type and is the world’s most tried and tested HA dermal filler available today. It is the benchmark for clinical excellence in its field. Its safety and effectiveness are clinically proven and supported by extensive clinical data with over a hundred documented studies. Restylane has been used since 1996 in more than twenty million treatments worldwide. Galderma, the manufacturer of Restylane, continually invests in research and development.

Restylane is produced by Galderma, a dermatology company that develops, manufactures and markets solutions for aesthetic and corrective treatments in more than seventy countries. The division offers a complete worldwide portfolio in the aesthetic field including the brands Restylane, Emervel, and Macrolane as well as other products improving patients’ health in the corrective field. The site in Uppsala, Sweden, where Restylane is produced is Galderma’s Global Center of Excellence for Aesthetic and Corrective solutions with state-of-the-art research, development and manufacturing facilities. After over a decade of clinical use, over twenty million treatments worldwide with continuous research and safety as top priority, Restylane has been proven to be safe, effective and long-lasting. Galderma continues to invest in a research and development, in the interest of improving further patient safety and new product development.